Learn about navigating regulatory pathways that advance promising biotherapies to daily patient care at RegenBio Summit: Transforming Next-Gen Biotherapeutics 2024. Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research within the Food and Drug Administration (FDA), will deliver a keynote address about guiding the development of new cell, gene and tissue therapies. Dr. Marks leads the Center within FDA that is responsible for ensuring that biological products are safe, effective and…
You may also like
Health & Wellness
Mayo Clinic Q and A: My mom has Alzheimer’s. What does that mean for me?
Editor’s Note: September is World Alzheimer’s Month DEAR MAYO CLINIC: I am part of what I hear called the Sandwich
Health & Wellness
Mayo Clinic Minute: Palliative medicine for cancer patients
Patients undergoing cancer treatments often use palliative medicine to cope with nausea, fatigue and other bothersome symptoms. Palliative medicine is